Epithelial to Mesenchymal Transition in Endomyocardial Biopsies from Orthotopic Heart Transplant Recipients
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Cardiac Failure"
DOI: 10.1016/j.cardfail.2018.07.448
Abstract: Introduction Heart transplant patients are at high risk of organ rejection and require close monitoring with frequent endomyocardial biopsies (EMB), especially during their first post-transplant year. We encountered a hypercellular, atypical endocardial lesion composed of… read more here.
Keywords: mesenchymal transition; endomyocardial biopsies; heart; transplant ... See more keywords
Vasculitis on Heart Transplant as an Emerging Prognostic Factor
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Heart and Lung Transplantation"
DOI: 10.1016/j.healun.2021.01.834
Abstract: Purpose Vasculitis had been considered a histopathological marker in severe form of both cellular and humoral rejection. However, in mild forms of rejections, it has not been considered a diagnostic and prognostic histopathologic criterion. Aim… read more here.
Keywords: heart; pamr mixed; endomyocardial biopsies; rejection ... See more keywords
Human cardiac progenitor cells with regenerative potential can be isolated and characterized from 3D-electro-anatomic guided endomyocardial biopsies.
Sign Up to like & getrecommendations! Published in 2017 at "International journal of cardiology"
DOI: 10.1016/j.ijcard.2017.02.106
Abstract: AIMS In the present study, we aimed to develop a percutaneous approach and a reproducible methodology for the isolation and expansion of Cardiac Progenitor Cells (CPCs) from EndoMyocardial Biopsies (EMB) in vivo. Moreover, in an… read more here.
Keywords: methodology; progenitor cells; endomyocardial biopsies; cpcs ... See more keywords
The utilization and safety of apixaban for therapeutic anticoagulation in heart transplant population requiring routine endomyocardial biopsies
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Transplantation"
DOI: 10.1111/ctr.14828
Abstract: Routine endomyocardial (EM) biopsies pose a challenge in the management of heart transplant recipients requiring anticoagulation. Apixaban is a direct‐acting oral anticoagulant (DOAC) with a short half‐life allowing for brief interruptions of anticoagulation for procedures.… read more here.
Keywords: routine endomyocardial; heart transplant; anticoagulation; endomyocardial biopsies ... See more keywords